These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 14328051)

  • 1. L-PHENYLALANINE MUSTARD (NSC-8806) IN UNCOMMON MALIGNANT DISEASE IN CHILDREN.
    GRINBERG R; NEMOTO T; DAO TL
    Cancer Chemother Rep; 1965 Apr; 45():63-7. PubMed ID: 14328051
    [No Abstract]   [Full Text] [Related]  

  • 2. L-PHENYLALANINE MUSTARD AS A TREATMENT FOR METASTATIC OSTEOGENIC SARCOMA IN CHILDREN.
    SULLIVAN MP; SUTOW WW; TAYLOR G
    J Pediatr; 1963 Aug; 63():227-37. PubMed ID: 14043064
    [No Abstract]   [Full Text] [Related]  

  • 3. HISTOPATHOLOGICAL CHANGES IN MALIGNANT MELANOMA AND NORMAL TISSUES FOLLOWING REGIONAL PERFUSION WITH L-PHENYLALANINE MUSTARD (L-SARCOLYSIN).
    SMITH JL; STEHLIN JS; CLARK RL
    Acta Unio Int Contra Cancrum; 1964; 20():451-4. PubMed ID: 14151957
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806).
    BERGSAGEL DE; SPRAGUE CC; AUSTIN C; GRIFFITH KM
    Cancer Chemother Rep; 1962 Aug; 21():87-99. PubMed ID: 13867794
    [No Abstract]   [Full Text] [Related]  

  • 5. THE BIOCHEMICAL MECHANISM OF ACTION OF L-PHENYLALANINE MUSTARD. I. DISTRIBUTION OF L-PHENYLALANINE MUSTARD-H3 IN TUMOR-BEARING RATS.
    MILNER AN; KLATT O; YOUNG SE; STEHLIN JS
    Cancer Res; 1965 Feb; 25():259-64. PubMed ID: 14264059
    [No Abstract]   [Full Text] [Related]  

  • 6. CLINICAL TRIAL OF P-DI(2-CHLOROETHYL)AMINO-L-PHENYLALANINE (MELPHALAN) IN MULTIPLE MYELOMA.
    ERIDANI S; TAGLIORETTI D; TISO R
    G Ital Chemioter; 1964; 11():93-9. PubMed ID: 14279690
    [No Abstract]   [Full Text] [Related]  

  • 7. ELDERFIELD PYRIMIDINE MUSTARD (NSC-23436) IN ACUTE LEUKEMIA IN CHILDREN--A PHASE I STUDY.
    HEYN R; NEWTON W; CARTER R
    Cancer Chemother Rep; 1963 Dec; 33():51-5. PubMed ID: 14102083
    [No Abstract]   [Full Text] [Related]  

  • 8. [ANTINEOPLASTIC ACTIVITY OF O-BIS(2-CHLOROETHYL) AMINO-DL-PHENYLALANINE (ORTHOSARCOLYSIN)].
    TRUSHEIKINA VI
    Vopr Onkol; 1964; 10():82-4. PubMed ID: 14339886
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a combination of mitomycin C (NSC-26980), phenylalanine mustard (NSC-14210), and vincristine (NSC-67574) in the treatment of osteogenic sarcoma.
    Jaffe N; Traggis D; Enriquez C
    Cancer Chemother Rep; 1971 Apr; 55(2):189-91. PubMed ID: 5286991
    [No Abstract]   [Full Text] [Related]  

  • 10. THE TREATMENT OF MALIGNANT DISEASE BY REGIONAL CHEMOTHERAPY.
    JOHNSTON ID
    Ulster Med J; 1963 Dec; 32(2):151-9. PubMed ID: 14105942
    [No Abstract]   [Full Text] [Related]  

  • 11. AMINO ACID DERIVATIVES OF DI-(2-CHLOROETHYL)-AMINE: THEIR EFFECT ON INCORPORATION OF HETEROLOGOUS AMINO ACIDS IN TUMOR AND ORGAN PROTEINS.
    NOVIKOVA MA
    Fed Proc Transl Suppl; 1964; 23():1043-6. PubMed ID: 14215261
    [No Abstract]   [Full Text] [Related]  

  • 12. VINCRISTINE (NSC-67574) IN UNCOMMON MALIGNANT DISEASE IN CHILDREN.
    HADDY TB; FERNBACH DJ; WATKINS WL; SULLIVAN MP; WINDMILLER J
    Cancer Chemother Rep; 1964 Sep; 41():41-5. PubMed ID: 14213141
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of hyperthermia in regional alkylating agent chemotherapy.
    Abdel-Wahab OI; Grubbs E; Viglianti BL; Cheng TY; Ueno T; Ko S; Rabbani Z; Curtis S; Pruitt SK; Dewhirst MW; Tyler DS
    Clin Cancer Res; 2004 Sep; 10(17):5919-29. PubMed ID: 15355925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-phenylalanine mustard (NSC-8806) administration in osteogenic sarcoma: an evaluation of dosage schedules.
    Sutow WW; Sullivan MP; Wilbur JR; Vietti TJ; Kaizer H; Nagamoto A
    Cancer Chemother Rep; 1971 Apr; 55(2):151-7. PubMed ID: 5286989
    [No Abstract]   [Full Text] [Related]  

  • 15. CORONARY DISEASE ASSOCIATED WITH INGESTION OF MUSTARD.
    BLAIR J
    Ohio State Med J; 1965 Aug; 61():732-4. PubMed ID: 14337556
    [No Abstract]   [Full Text] [Related]  

  • 16. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
    BOYLAND E; KINDER CH; WILLIAMS K
    Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
    [No Abstract]   [Full Text] [Related]  

  • 17. [ALLERGY TO MUSTARD: APROPOS OF A PRIVILEGED CASE].
    BLAMOUTIER P
    Rev Fr Allergol; 1965; 19():46-7. PubMed ID: 14290622
    [No Abstract]   [Full Text] [Related]  

  • 18. COMPARATIVE RESPONSE OF A SPECTRUM OF TRANSPLANTABLE RAT NEOPLASMS TO NITROGEN MUSTARD, TRIETHYLENEMELAMINE, AND A GROUP OF BENZALDEHYDE MUSTARD DERIVATIVES.
    DUNNING WF; CURTIS MR
    Cancer Chemother Rep; 1964 Mar; 36():5-19. PubMed ID: 14152277
    [No Abstract]   [Full Text] [Related]  

  • 19. A CASE OF SUSPECTED POISONING OF DAIRY COWS BY WHITE MUSTARD SEEDS (SINAPIS ALBA).
    HOLMES RG
    Vet Rec; 1965 Apr; 77():480. PubMed ID: 14331418
    [No Abstract]   [Full Text] [Related]  

  • 20. EVALUATION OF MELPHALAN (NSC-8806) IN TREATMENT OF MULTIPLE MYELOMA.
    BROOK J; BATEMAN JR; STEINFELD JL
    Cancer Chemother Rep; 1964 Mar; 36():25-34. PubMed ID: 14152271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.